Published in Basic Res Cardiol on May 21, 1992
Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol (1995) 1.71
Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev (2010) 1.18
Role of cytokines in myocardial ischemia and reperfusion. Mediators Inflamm (1997) 0.88
Do reciprocal interactions between cell stress proteins and cytokines create a new intra-/extra-cellular signalling nexus? Cell Stress Chaperones (2013) 0.84
Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. J Clin Invest (1993) 0.83
The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev (2012) 0.82
Cytoprotective mechanisms in cultured cardiomyocytes. Mol Cell Biochem (1997) 0.80
Influx of macrophages into livers of rats treated with hepatotoxicants (thioacetamide, allyl alcohol, D-galactosamine) induces expression of HSP25. J Mol Histol (2006) 0.77
Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart. Exp Clin Cardiol (2002) 0.76
Heat shock protein gene expression and survival in critical illness. Crit Care (2000) 0.75
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol (2009) 1.77
Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival. AIDS (1998) 1.51
Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35
Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study. Eur J Clin Nutr (2008) 1.20
Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest (2007) 1.16
Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood (1979) 1.16
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol (1994) 1.10
Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol (1994) 1.09
Effect of aminoglycosides on proximal tubular membranes of the human kidney. Eur J Clin Pharmacol (1978) 1.09
Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol (1993) 1.07
Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol). Clin Sci Mol Med Suppl (1976) 1.05
Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension. Klin Wochenschr (1976) 0.99
Immune-mediated mesangial cell injury--biosynthesis and function of prostanoids. Kidney Int (1990) 0.95
Effects of cefotaxime on the proximal tubules of the human kidney. J Antimicrob Chemother (1980) 0.95
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Ann Oncol (2006) 0.91
Effects of dopamine on kidney function and on the adenyl cyclase phosphodiesterase system in man. Eur J Clin Invest (1976) 0.86
Cyclooxygenase inhibition enhances rat interleukin 1 beta-induced growth of rat mesangial cells in culture. Am J Physiol (1990) 0.86
Effects of various cephalosporins on the proximal tubule of the human kidney. Eur J Clin Pharmacol (1978) 0.86
Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int (1996) 0.85
Angiotensin II-induced proliferation of cultured murine mesangial cells: inhibitory role of atrial natriuretic peptide. J Am Soc Nephrol (1992) 0.85
Improving anemia by hemodialysis: effect of serum erythropoietin. Kidney Int (1980) 0.85
Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin-converting enzyme inhibitors. Transplantation (1993) 0.84
Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. Clin Nephrol (1989) 0.84
Lymphocyte transformation test in a group of foundry workers exposed to beryllium and non-exposed controls. Eur J Respir Dis Suppl (1986) 0.84
Testosterone therapy for anaemia in maintenance dialysis. Br Med J (1971) 0.84
Effects of dopamine on kidney function. Proc R Soc Med (1977) 0.83
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Contrib Nephrol (1989) 0.83
Angiotensinase A (aminopeptidase A): properties of chromatographically purified isoforms from human kidney. J Chromatogr (1992) 0.82
Angiotensin II stimulates cellular hypertrophy of LLC-PK1 cells through the AT1 receptor. Nephrol Dial Transplant (1993) 0.82
In vitro approach to 'uremic cardiomyopathy'. Nephron (1993) 0.82
Synthesis of shock proteins in cultured fetal mouse myocardial cells. Exp Cell Res (1989) 0.81
Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats. Lab Invest (1989) 0.81
Occurrence of adenyl cyclase activity in human erythrocytes. Blut (1974) 0.81
Tumor M2-PK levels in haematological malignancies. Anticancer Res (2003) 0.81
Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. Exp Nephrol (1997) 0.80
Cytoprotective mechanisms in cultured cardiomyocytes. Mol Cell Biochem (1997) 0.80
Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury. Kidney Int (1992) 0.80
Elimination of brush border membrane protein in urine caused by toxic alterations of the tubular cell. Contrib Nephrol (1981) 0.80
Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with stable essential hypertension and in normotensive subjects. Clin Sci Mol Med Suppl (1978) 0.79
Adenylate cyclase activity and cAMP content of human platelets in uraemia. Eur J Clin Invest (1982) 0.79
[Nephrotic syndrome of the adult. 1]. Dtsch Med Wochenschr (1971) 0.79
Effects of calcium channel blockers on stress protein synthesis in cardiac myocytes. J Cardiovasc Pharmacol (1991) 0.79
GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia (1995) 0.79
Routine diagnosis with PhastSystem compared to conventional electrophoresis: automated sodium dodecyl sulfate-polyacrylamide gel electrophoresis, silver staining and western blotting of urinary proteins. Electrophoresis (1989) 0.79
Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. Eur J Clin Invest (2004) 0.79
Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity. Br J Clin Pharmacol (1980) 0.79
Isolation and characterization of dipeptidyl aminopeptidase IV from human kidney cortex. Clin Chim Acta (1989) 0.79
Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension. Clin Sci Mol Med Suppl (1976) 0.78
Urinary excretion of dipeptidyl aminopeptidase i.v. in patients with renal diseases. Clin Nephrol (1990) 0.78
Isolation and partial characterization of angiotensinase A and aminopeptidase M from urine and human kidney by lectin affinity chromatography and high-performance liquid chromatography. J Chromatogr (1990) 0.78
The effect of prostaglandin E2 on mRNA expression and secretion of collagens I, III, and IV and fibronectin in cultured rat mesangial cells. J Am Soc Nephrol (1994) 0.78
Glomerular angiotensinase A in the rat: increase of enzyme activity following renal ablation. Kidney Int (1990) 0.78
Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration. Clin Nephrol (1976) 0.78
Type III hyperlipoproteinemia acquired by liver transplantation. Transplantation (1993) 0.78
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany. Zentralbl Bakteriol (1995) 0.78
Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure. Kidney Int Suppl (1989) 0.78
Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies. Proc Eur Dial Transplant Assoc (1983) 0.78
Monitoring drug nephrotoxicity. Quantitative estimation of human kidney brush border antigens in urine as a specific marker of tubular damage. Contrib Nephrol (1984) 0.78
Peptidase-associated antigens as markers of differentiation in human kidney and renal adenocarcinoma. Cell Mol Biol (1988) 0.78
Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies. Eur J Clin Invest (1976) 0.78
Antituberculous drugs in kidney transplant recipients treated with cyclosporine. Transplantation (1993) 0.77
Characterization and clinical role of glomerular and tubular proteases from human kidney. Adv Exp Med Biol (1988) 0.77
Micropuncture study of isolated perfused rat kidney. Am J Physiol (1967) 0.77
A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition. J Am Soc Nephrol (1992) 0.77
Cocultures of fetal and adult cardiomyocytes yield rhythmically beating rod shaped heart cells from adult rats. In Vitro Cell Dev Biol Anim (1995) 0.77
Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function. Contrib Nephrol (1988) 0.77
Shedding and repair of renal cell membranes following drug-induced nephrotoxicity in humans. Eur J Clin Pharmacol (1993) 0.77
Kidney- and serum derived proteins in urine of patients suffering from renal diseases or arterial hypertension. Klin Wochenschr (1989) 0.77
The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury. J Am Soc Nephrol (1991) 0.76
Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease. Contrib Nephrol (1988) 0.76
Occult blood loss and iron balance in chronic renal failure. Proc Eur Dial Transplant Assoc (1976) 0.76
Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. Am J Nephrol (1991) 0.76
HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapy. Leuk Lymphoma (1998) 0.76
Differences in calcium kinetic pattern between CAPD and HD patients. Clin Nephrol (1995) 0.76
Thromboxane mediates glomerular haemodynamics in a model of chronic glomerular disease. Eur J Clin Invest (1992) 0.76
In vitro studies on the cardiotoxicity of chemotherapeutics. Chemotherapy (1990) 0.76
Tumor necrosis factor-alpha-induced cytoprotective mechanisms in cardiomyocytes. Analysis by mRNA phenotyping. Ann N Y Acad Sci (1996) 0.76
Effect of hyperthyroidism on clearance and secretion of glucagon in man. Exp Clin Endocrinol Diabetes (2011) 0.76
Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron (1988) 0.75
Progressive renal failure in a patient after one and two-thirds nephrectomy. Klin Wochenschr (1988) 0.75
Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation. Neth J Med (1985) 0.75
Desferrioxamine treatment for aluminium and iron overload in uraemic patients by haemodialysis or haemofiltration. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.75
Characterization and clinical significance of membrane bound proteases from human kidney cortex. Adv Exp Med Biol (1984) 0.75
Early changes of plasma lipid status and glucose tolerance during the course of chronic renal failure. Contrib Nephrol (1984) 0.75
[Immunodiagnosis of kidney tubular cell injuries using specific anti-membrane antibodies]. Immun Infekt (1984) 0.75
Human immunodeficiency virus antibody screening in patients on renal replacement therapy: prevalence of false-positive results. Nephrol Dial Transplant (1987) 0.75
Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin. Scand J Urol Nephrol Suppl (1985) 0.75
[Detection and treatment of chronic renal failure in general practice, central problem of the responsibilities of the nephrology specialist]. Wien Med Wochenschr (1986) 0.75
Is the potential nephrotoxicity of drugs predictable? Experiences with a volunteer model. Contrib Nephrol (1984) 0.75
[The kidney and arterial hypertension]. Lebensversicher Med (1985) 0.75
[Results of transplantation of kidneys from related living donors]. Urologe A (1982) 0.75
[Spontaneous lysis of acute Leriche syndrome]. Rontgenblatter (1986) 0.75
Hemodynamic response to chronic anemia in renal failure. Contrib Nephrol (1984) 0.75
[Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation]. Dtsch Med Wochenschr (1986) 0.75
Hemodynamics during hemodialysis with dialyzers of high hydraulic permeability. Contrib Nephrol (1985) 0.75
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects. Klin Wochenschr (1986) 0.75
[Pulmonary manifestations of malaria]. Rofo (1987) 0.75
Baroreflex in patients undergoing hemodialysis and hemofiltration. Contrib Nephrol (1984) 0.75
Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia. Klin Wochenschr (1982) 0.75